BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3286444)

  • 41. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.
    Wang J; Takeuchi T; Tanaka S; Kubo SK; Kayo T; Lu D; Takata K; Koizumi A; Izumi T
    J Clin Invest; 1999 Jan; 103(1):27-37. PubMed ID: 9884331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
    Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
    J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutant insulin syndromes.
    Vinik A; Bell G
    Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetics of type 2 diabetes mellitus.
    Malecki MT
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
    Hegele RA
    Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.